Publications
Targeted Delivery for Cardiac Regeneration: Comparison of Intra-coronary Infusion and Intra-myocardial Injection in Porcine Hearts." Frontiers in Cardiovascular Medicine 9 (2022).
"Tension Creates an Endoreplication Wavefront that Leads Regeneration of Epicardial Tissue." Dev Cell 42, no. 6 (2017): 600-615.e4.
"Three-dimensional cultures of cardiomyocytes for electrophysiological studies of cardiac muscle." Annals of Biomedical Engineering 28, no. SUPPL 1 (2000): S - 54.
"Three-dimensional environment promotes in vitro differentiation of cardiac myocytes." Annual International Conference of the Ieee Engineering in Medicine and Biology Proceedings 1 (1999): 128-.
"Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease." Communications Biology 4, no. 1 (2021).
"Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation." Annals of Surgery 235, no. 2 (2002): 292-296.
"Tissue engineering of functional cardiac muscle: Molecular, structural, and electrophysiological studies." American Journal of Physiology Heart and Circulatory Physiology 280, no. 1 49-1 (2001): H168-H178.
"Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies." American Journal of Physiology Heart and Circulatory Physiology 280, no. 1 (2001): H168-H178.
"Tissue engineering of functional skeletal muscle: challenges and recent advances." Ieee Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society 27, no. 5 (2008): 109-113.
"Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs." Scientific Reports 6 (2016).
"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes." Biomaterials 34, no. 23 (2013): 5813-5820.
"Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers." Toxicological Sciences 176, no. 1 (2020): 124-136.
"Toward improved understanding of cardiac development and congenital heart disease: The advent of cardiac organoids." The Journal of Thoracic and Cardiovascular Surgery 164, no. 6 (2022): 2013-2018.
"Towards a functional tissue engineered cardiac muscle." Annual International Conference of the Ieee Engineering in Medicine and Biology Proceedings 1 (1999): 125-.
"Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming." Plos One 8, no. 5 (2013): e63577.
"Translating musculoskeletal bioengineering into tissue regeneration therapies." Science Translational Medicine 14, no. 666 (2022).
"Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles." Annals of Biomedical Engineering 42, no. 7 (2014): 1391-1405.
"Whole cell imaging based on wide-field interferometric phase microscopy and its application to cardiomyocytes." Progress in Biomedical Optics and Imaging Proceedings of Spie 7904 (2011).
"Whole-cell-analysis of live cardiomyocytes using wide-field interferometric phase microscopy." Biomedical Optics Express 1, no. 2 (2010): 706-719.
"WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs." Stem Cell Reports 1, no. 1 (2013): 46-52.
"X-Linked Inhibitor of Apoptosis Protein (XIAP)-Mediated Attenuation of Apoptosis Using a Novel Cardiac Enhanced Adeno-Associated Viral Vector." Circulation 122, no. 21 (2010).
"X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector." Hum Gene Ther 23, no. 6 (2012): 635-646.
"